Biden’s Drug Pricing Push, ChatGPT for Business, & Meta’s Disinformation Discovery 8/29/23

The Biden administration has unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. CNBC’s Bertha Coombs  and Centers for Medicare and Medicaid Services Administrator, Chiquita Brooks-Lasure, discuss the announcement, how the list of drugs were chosen, and more. Amazon CEO Andy Jassy is reportedly ready to let go of remote employees who’d rather stay remote, and OpenAI is launching its chatbot business tier, called ChatGPT Enterprise. Plus, CNBC’s Eamon Javers reports, Meta says it has disrupted a disinformation campaign linked to Chinese law enforcement, what the platform has called the “largest known cross-platform covert influence operation in the world.”Bertha Coombs 15:50Chiquita Brooks-LaSure 20:33Eamon Javers 28:17In this episode:Becky Quick, @BeckyQuickJoe Kernen, @JoeSquawkEamon Javers, @EamonJaversChiquita Brooks-LaSure, @BrooksLaSureCMSBertha Coombs, @berthacoombsKatie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.